MedPage Today HCV HOT TOPICS - 10 Day Video Series

MedPage Today HCV HOT TOPICS -  10 Day Video Series

MedPage Today invited specialists from leading medical institutions to weigh in on the latest advancements in hepatitis C with one question each day for 10 days.

(Post Dates Subject to Change)

Who is at risk and how can they be reached?
(Post date: 05/18/2015)

Is current screening practice working?
(Post date: 05/19/2015)

Should all patients be treated as soon as possible or is it useful to wait in some /many/most cases?
(Post date: 05/20/2015)

How should patients with HIV treated, especially in the new era of direct-acting agents?
(Post date: 05/21/2015)

Will there still be a role for ribavirin and pegylated interferon-alfa?
(Post date: 05/22/2015)

What will be the impact of DAAs on diagnosis and management?
(Post date: 05/26/2015)

DAAS in the Pipeline: What‘s coming?
(Post date: 05/27/2015)

Some treatments are eight weeks with one or two pills a day. Can it get shorter/easier?
(Post date: 05/28/2015)

The DAAS are expensive; how can patients and insurers afford them?
(Post date: 05/29/2015)

What are the co-factors that increase severity of HCV disease and how should they be managed?
(Post date: 06/01/2015)